Related Experiment Video
Updated: Jun 20, 2026

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
Published on: April 1, 2022
Phosphorylation of myocardin by extracellular signal-regulated kinase
Sebastien Taurin1, Nathan Sandbo, Douglas M Yau
1Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA.
Abstract:
The contractile phenotype of smooth muscle (SM) cells is controlled by serum response factor (SRF), which drives the expression of SM-specific genes including SM alpha-actin, SM22, and others. Myocardin is a cardiac and SM-restricted coactivator of SRF that is necessary for SM gene transcription. Growth factors inducing proliferation of SM cells inhibit SM gene transcription, in a manner dependent on the activation of extracellular signal-regulated kinases ERK1/2. In this study, we found that ERK1/2 phosphorylates mouse myocardin (isoform B) at four sites (Ser(812), Ser(859), Ser(866), and Thr(893)), all of which are located within the transactivation domain of myocardin. The single mutation of each site either to alanine or to aspartate has no effect on the ability of myocardin to activate SRF. However, the phosphomimetic mutation of all four sites to aspartate (4xD) significantly impairs activation of SRF by myocardin, whereas the phosphodeficient mutation of all four sites to alanine (4xA) has no effect. This translates to a reduced ability of the 4xD (but not of 4xA) mutant of myocardin to stimulate expression of SM alpha-actin and SM22, as assessed by corresponding promoter, mRNA, or protein assays. Furthermore, we found that phosphorylation of myocardin at these sites impairs its interaction with acetyltransferase, cAMP response element-binding protein-binding protein, which is known to promote the transcriptional activity of myocardin. In conclusion, we describe a novel mode of modulation of SM gene transcription by ERK1/2 through a direct phosphorylation of myocardin.
Insights
Extracellular signal-regulated kinases (ERK1/2) directly phosphorylate myocardin, a key protein in smooth muscle (SM) gene expression. This phosphorylation impairs myocardin
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Smooth muscle (SM) cell contractile phenotype relies on serum response factor (SRF) and SM-specific genes.
- Myocardin, a SRF coactivator, is crucial for SM gene transcription.
- Growth factors activate ERK1/2, inhibiting SM gene transcription during SM cell proliferation.
Purpose of the Study:
- To investigate the mechanism by which ERK1/2 regulates SM gene transcription.
- To determine if ERK1/2 directly interacts with and modifies myocardin.
- To elucidate the functional consequences of myocardin phosphorylation by ERK1/2.
Main Methods:
- Site-directed mutagenesis of mouse myocardin (isoform B) at four identified phosphorylation sites.
- Assays to evaluate myocardin's ability to activate SRF and stimulate SM gene expression (promoter, mRNA, protein).
- Analysis of myocardin's interaction with cAMP response element-binding protein-binding protein (CBP).
Main Results:
- ERK1/2 phosphorylates mouse myocardin at four specific sites within its transactivation domain.
- Phosphomimetic mutation (4xD) of these sites significantly impairs SRF activation and SM gene expression.
- Phosphorylation at these sites reduces myocardin's interaction with CBP, a transcriptional coactivator.
Conclusions:
- ERK1/2 directly phosphorylates myocardin, representing a novel regulatory mechanism for SM gene transcription.
- This phosphorylation modulates myocardin's transcriptional activity and interaction with coactivators.
- Understanding this pathway offers insights into smooth muscle cell biology and potential therapeutic targets.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways
Amplifying Signals via Enzymatic Cascade
Intracellular Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway

